Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Many patients report feeling more energized within 24 to 72 hours after their first injection
WHY CHOOSE THIS PRODUCT This advanced dual peptide formulation delivers targeted recovery and regenerative support
Chronic Insomnia Double-Blind Trial The double-blind matched-pairs study by Schneider-Helmert (1988) evaluated DSIP at 25 nmol/kg IV administered on three consecutive afternoons in 16 chronic insomniac patients
no LD50 established even at very high doses in rodents No Hormonal Effects: Does not affect testosterone, estrogen, growth hormone, or other hormonal axes Gastric Origin: Derived from a naturally occurring human gastric protein, suggesting good biological compatibility Stability: Unusually stable in gastric acid, supporting oral administration potential Reported Effects: Anecdotal reports of fatigue, nausea in some research subjects TB-500 Safety Profile: (PMID: 20536472) Note: Published safety data is primarily available for Thymosin Beta-4
